Sickle cell disease--pathophysiology, clinical and diagnostic implications

Alexandra Dorn-Beineke1, Thomas Frietsch

  • 1Department of Clinical Chemistry, Faculty of Clinical Medicine, Mannheim University, Heidelberg, Heidelberg, Germany. alexandra.dorn-beineke@ikc.ma.uni-heidelberg.de

Insights

Sickle cell disease (SCD) diagnosis is improving, but symptom severity factors remain unclear. Red blood cell lysis resistance shows promise as an additional diagnostic tool for SCD patients with sickle cell hemoglobin (HbS).

Area of Science:

  • Hematology
  • Medical Diagnostics
  • Genetics

Background:

  • Sickle cell disease (SCD) is a genetic blood disorder with complex pathophysiology.
  • Current diagnostic methods for sickle cell hemoglobin (HbS) are efficient but do not fully explain symptom variability.
  • Understanding factors influencing SCD severity is crucial for patient management.

Purpose of the Study:

  • To review the current knowledge on SCD pathophysiology, clinical complications, and diagnostic techniques.
  • To highlight red blood cell lysis resistance as a potential additional diagnostic tool in SCD.
  • To identify areas needing further research in SCD diagnostics and pathophysiology.

Main Methods:

  • Literature review of existing studies on sickle cell disease.
  • Analysis of current diagnostic approaches for sickle cell hemoglobin (HbS) status.
  • Evaluation of red blood cell lysis resistance as a diagnostic marker.

Main Results:

  • Fast and economical laboratory methods exist for determining sickle cell hemoglobin (HbS) status.
  • The pathophysiology of SCD is well-studied, but factors influencing symptom severity and some lab findings require further investigation.
  • Red blood cell lysis resistance is proposed as a valuable additional diagnostic tool.

Conclusions:

  • While SCD diagnostics have advanced, further research is needed on factors affecting disease severity.
  • Red blood cell lysis resistance warrants further investigation as a diagnostic aid for patients with sickle cell hemoglobin (HbS).
  • Continued research is essential to fully understand and manage SCD complications.

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Introduction to Language of Pathophysiology l01:25

Introduction to Language of Pathophysiology l

Pathophysiology investigates how biological mechanisms—typically starting at the cellular level—disrupt normal bodily functions. It bridges anatomy and physiology to explain the progression of disease. With this foundation, it is important to understand the following key terms used to describe disease processes: Diagnosis:The process of identifying a disease using clinical evaluation, including signs (objective evidence like rashes), symptoms (subjective experiences like pain), laboratory test...